NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Jester, most of my life I've known investors who were certain that many things were material events, but companies didn't PR these things, so in their judgement, they weren't.

The fact that DCVax-L was put on the High Cost List in itself was found in a public document, I believe the company need not PR it because it's already been publicly revealed.

I frankly don't know that all correspondence with the regulator during the approval process isn't also considered private and not to be revealed. If that's the case, and if the company and regulators discussed a tumor agnostic label and the regulators said, show us your proof, while it's certainly huge if they accept it, but noting would ever be said if they took a look, but told the company, do some trials to prove it. Therefore, I don't believe the company would reveal it, and frankly think the regulators would have told them not to.

Some companies certainly are far more open than NWBO, but many of them are far more interested in bringing in new investors than they are getting approvals, they keep the money flowing by claims that their drug, developed nearly half a century ago, is the cure for something, and they believe their latest target is that disease. I'm certainly speaking of CVM, but there are others I believe as well.

Gary